Duvas Pharma Private Limited
About Duvas Pharma Private Limited
Data last updated:
Duvas Pharma Private Limited is a private limited company based in Pune City, Maharashtra, India. It was incorporated on 22 February 2023.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U46497PN2023PTC218269. Its GSTIN is 27AAJCD8970A1ZJ (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kaiwala Gajanan Mandole and Gajanan Ramdas Mandole.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune City, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.74 Lakh, a growth of 65% compared to the previous year. For the same year it recorded a net profit of ₹1.4 Lakh (net margin 6.8%) and EBITDA of ₹1.65 Lakh (EBITDA margin 8%).
As per MCA filings, the company has open charges of ₹3.15 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address123A149150 Narayanpeth Off No 3 Kelkar Rd, Narayan Peth, Pune City, Maharashtra, India – 411030
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Duvas Pharma Private Limited
The main business activities of Duvas Pharma are manufacturing and wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers manufacture of wood and of products of wood and cork, except furniture; manufacture of articles of straw and plaiting materials and wholesale trade, except of motor vehicles and motorcycles. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 16 | Manufacture of wood and of products of wood and cork, except furniture; manufacture of articles of straw and plaiting materials | Locked |
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Duvas Pharma Private Limited FY 2025 filings available
Duvas Pharma Private Limited reported revenue of ₹20.74 Lakh (up 65% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Duvas Pharma Private Limited
Revenue rose 65% in the latest year. EBITDA rose 131% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Duvas Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹1.65 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.4 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Duvas Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 8% | •••• | •••• |
| Net Profit Margin | 6.8% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Duvas Pharma are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Duvas Pharma Private Limited
Duvas Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kaiwala Gajanan Mandole | Director | 22 Feb 2023 | 3 Years 7 Months | Current |
| Gajanan Ramdas Mandole | Director | 24 Aug 2024 | 2 Years 1 Months | Current |
Charges & Borrowings of Duvas Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Dec 2024 | Abhyudaya Co-Operative Bank Limited | ₹3.15 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Duvas Pharma Private Limited
Employment history and EPFO contributions of people linked to Duvas Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Duvas Pharma Private Limited
Duvas Pharma Private Limited has 4 board changes on record since 2023: 2 appointments and 2 cessations. The latest: Gajanan Ramdas Mandole ceased to be Additional Director on 30 Dec 2024.
Credit Ratings, Litigation & Regulatory Alerts for Duvas Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Duvas Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Duvas Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Duvas Pharma Private Limited
Duvas Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCD8970A1ZJ | Maharashtra | Active | 23 May 2023 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Duvas Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Duvas Pharma Private Limited
Duvas Pharma is an active private limited company based in Pune City, Maharashtra, India. It was incorporated on 22 February 2023 (3+ years old) and is registered under CIN U46497PN2023PTC218269.
Duvas Pharma reported revenue of ₹20.74 Lakh for FY 2025 (up 65% YoY).
Duvas Pharma has 2 current directors:
- Kaiwala Gajanan Mandole - Director
- Gajanan Ramdas Mandole - Director
Duvas Pharma reported a net profit of ₹1.4 Lakh (net margin 6.8%) and EBITDA of ₹1.65 Lakh (EBITDA margin 8%) for FY 2025, as per its filed financial statements.
The GSTIN of Duvas Pharma is 27AAJCD8970A1ZJ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Duvas Pharma is U46497PN2023PTC218269. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Duvas Pharma was incorporated on 22 February 2023, making it 3+ years old. It is registered with the Registrar of Companies, Pune.
Gajanan Ramdas Mandole ceased to be Additional Director on 30 Dec 2024. Gajanan Ramdas Mandole was appointed as Director on 24 Aug 2024. Vandana Deepak Bhosle ceased to be Director on 24 Aug 2024. Duvas Pharma has 4 board changes on record in total.
The registered office of Duvas Pharma is at 123A149150 Narayanpeth Off No 3 Kelkar Rd, Narayan Peth, Pune City, Maharashtra, India – 411030.
Duvas Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.